Luana Colloca1,2,3, Titilola Akintola4,5, Nathaniel R Haycock4, Maxie Blasini4, Sharon Thomas4, Jane Phillips6, Nicole Corsi4, Lieven A Schenk4,5, Yang Wang4,5. 1. Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, Maryland, USA, colloca@umaryland.edu. 2. Departments of Anesthesiology and Psychiatry, School of Medicine, University of Maryland, Baltimore, Maryland, USA, colloca@umaryland.edu. 3. Center to Advance Chronic Pain Research, University of Maryland, Baltimore, Maryland, USA, colloca@umaryland.edu. 4. Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, Maryland, USA. 5. Center to Advance Chronic Pain Research, University of Maryland, Baltimore, Maryland, USA. 6. Department of Neural and Pain Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, USA.
Abstract
INTRODUCTION: Many clinical trials fail because of placebo responses. Prior therapeutic experiences and patients' expectations may affect the capacity to respond to placebos in chronic disorders. OBJECTIVE: The scope of this study in 763 chronic orofacial pain and healthy study participants was to compare the magnitude and prevalence of placebo effects and determine the putative role of prior therapeutic experiences vs. expectations. METHODS: We tested placebo propensity in a laboratory setting by using 2 distinct levels of individually tailored painful stimulations (high pain and low pain) to reinforce expectations and provide a hypoalgesic experience (conditioning phase). Afterwards, both levels of pain were surreptitiously set at a moderate pain level to test for placebo effects (testing phase). Pain and expectation ratings were assessed as primary outcomes using visual analog scales. RESULTS: In both chronic pain and healthy participants, placebo effects were similar in magnitude, with the larger prevalence of responders in the healthy participants. Although chronic pain participants reported higher pain relief expectations, expectations did not account for the occurrence of placebo effects. Rather, prior experience via conditioning strength mediated placebo effects in both pain and healthy participants. CONCLUSIONS: These findings indicate that participants with chronic pain conditions display robust placebo effects that are not mediated by expectations but are instead directly linked to prior therapeutic experiences. This confirms the importance of assessing the therapeutic history while raising questions about the utility of expectation ratings. Future research is needed to enhance prediction of responses to placebos, which will ultimately improve clinical trial designs.
INTRODUCTION: Many clinical trials fail because of placebo responses. Prior therapeutic experiences and patients' expectations may affect the capacity to respond to placebos in chronic disorders. OBJECTIVE: The scope of this study in 763 chronic orofacial pain and healthy study participants was to compare the magnitude and prevalence of placebo effects and determine the putative role of prior therapeutic experiences vs. expectations. METHODS: We tested placebo propensity in a laboratory setting by using 2 distinct levels of individually tailored painful stimulations (high pain and low pain) to reinforce expectations and provide a hypoalgesic experience (conditioning phase). Afterwards, both levels of pain were surreptitiously set at a moderate pain level to test for placebo effects (testing phase). Pain and expectation ratings were assessed as primary outcomes using visual analog scales. RESULTS: In both chronic pain and healthy participants, placebo effects were similar in magnitude, with the larger prevalence of responders in the healthy participants. Although chronic painparticipants reported higher pain relief expectations, expectations did not account for the occurrence of placebo effects. Rather, prior experience via conditioning strength mediated placebo effects in both pain and healthy participants. CONCLUSIONS: These findings indicate that participants with chronic pain conditions display robust placebo effects that are not mediated by expectations but are instead directly linked to prior therapeutic experiences. This confirms the importance of assessing the therapeutic history while raising questions about the utility of expectation ratings. Future research is needed to enhance prediction of responses to placebos, which will ultimately improve clinical trial designs.
Authors: Javeria A Hashmi; Alex T Baria; Marwan N Baliki; Lejian Huang; Thomas J Schnitzer; Vania A Apkarian Journal: Pain Date: 2012-09-15 Impact factor: 6.961
Authors: Luana Colloca; Yang Wang; Pedro E Martinez; Yen-Pei C Chang; Kathleen A Ryan; Colin Hodgkinson; David Goldman; Susan G Dorsey Journal: Pain Date: 2019-08 Impact factor: 7.926
Authors: Etienne Vachon-Presseau; Taha B Abdullah; Sara E Berger; Lejian Huang; James W Griffith; Thomas J Schnitzer; A Vania Apkarian Journal: Pain Date: 2022-05-01 Impact factor: 7.926
Authors: Kristen R Weaver; Mari A Griffioen; N Jennifer Klinedinst; Elizabeth Galik; Ana C Duarte; Luana Colloca; Barbara Resnick; Susan G Dorsey; Cynthia L Renn Journal: Front Pain Res (Lausanne) Date: 2022-01-28